DUBLIN--(BUSINESS WIRE)--The "Global BREO Ellipta Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global BREO ellipta drugs market is driven ...
* Today's filing is based upon data generated from comprehensive clinical development programme for FF/VI in asthma * sNDA is seeking approval for two dose regimens, 100/25mcg and 200/25mcg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback